ClinicalTrials.gg
CompletedNCT01673633Updated Aug 28, 2012

Sacroiliitis in Systemic Sclerosis

An observational study in Systemic Sclerosis, Sacroiliitis and Inflammatory Back Pain, sponsored by Cukurova University. Completed. Open to participants aged 16 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2012-08-28.

Sponsored by Cukurova University · Observational

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
175
Ages
16 Years and older
Sex
All
01

Study summary

One of the major problems of systemic sclerosis (SSc) patients is suggested to be articular involvement. Mostly involved joints in SSc were reported as wrist, carpometacarpal-interphalangeal, foot, knee, hip and shoulder however there have been little knowledge on sacroiliac joint. Here the investigators plan a study on the involvement of this joint in SSc.

02

Conditions studied

  • Systemic Sclerosis
  • Sacroiliitis
  • Inflammatory Back Pain
03

In context

Scleroderma, Systemic

610 studies on the registry are indexed under Scleroderma, Systemic; 218 are open to participants now.

This study's enrollment of 175 is above the median of 100 across 145 observational studies indexed under Scleroderma, Systemic.

Browse Scleroderma, Systemic studies →

Lead sponsor

Cukurova University is the lead sponsor of 259 studies on the registry; 50 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Consecutive systemic sclerosis and rheumatoid arthritis patients and healthy volunteers

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients diagnosed as systemic sclerosis and rheumatoid arthritis and healthy volunteers

Exclusion criteria

Exclusion Criteria:

  • Not giving
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
175 participants (actual)

Groups and cohorts

  • SSc

    Sacroiliitis

  • Rheumatoid arthritis

    Sacroiliitis

  • Healthy controls

    Sacroiliitis

06

What researchers measure

Primary outcomes

  1. The frequency of sacroiliitis in systemic sclerosis

    Time frame: One year

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 28, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01673633
Responsible party
Didem Arslan Tas (Internist and rheumatologist, Cukurova University) — Principal investigator
First posted
Aug 28, 2012
Start date
Jan 2012
Last update
Aug 28, 2012
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion